Cited by 774Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 173 of the 175 references it cites were found in a registry or an index.

Molecular mechanisms of neurodegeneration in Alzheimer's disease

Open access

Crews, L., Masliah, E.·2010·Human Molecular Genetics

DOI 10.1093/hmg/ddq160PMC PMC2875049

Open this paper in CoChat — free account Open PDF

Abstract

Alzheimer's disease (AD) is characterized by cognitive impairment, progressive neurodegeneration and formation of amyloid-beta (Abeta)-containing plaques and neurofibrillary tangles composed of hyperphosphorylated tau. The neurodegenerative process in AD is initially characterized by synaptic damage accompanied by neuronal loss. In addition, recent evidence suggests that alterations in adult neurogenesis in the hippocampus might play a role. Synaptic loss is one of the strongest correlates to the cognitive impairment in patients with AD. Several lines of investigation support the notion that the synaptic pathology and defective neurogenesis in AD are related to progressive accumulation of Abeta oligomers rather than fibrils. Abnormal accumulation of Abeta resulting in the formation of toxic oligomers is the result of an imbalance between the levels of Abeta production, aggregation and clearance. Abeta oligomers might lead to synaptic damage by forming pore-like structures with channel activity; alterations in glutamate receptors; circuitry hyper-excitability; mitochondrial dysfunction; lysosomal failure and alterations in signaling pathways related to synaptic plasticity, neuronal cell and neurogenesis. A number of signaling proteins, including fyn kinase; glycogen synthase kinase-3beta (GSK3beta) and cyclin-dependent kinase-5 (CDK5), are involved in the neurodegenerative progression of AD. Therapies for AD might require the development of anti-aggregation compounds, pro-clearance pathways and blockers of hyperactive signaling pathways.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/hmg/ddq160

Cites

173 of 173 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The Ki-67 protein: From the known and the unknown
Scholzen, T. E., & Gerdes, J. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200003)182:3 · Cited by 4,707
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Self-citation
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
More hippocampal neurons in adult mice living in an enriched environment
Kempermann, G., Kuhn, H. G., & Gage, F. H. (1997) · Nature · doi:10.1038/386493a0 · Cited by 3,586
Mechanisms and Functional Implications of Adult Neurogenesis
Zhao, C., Deng, W., & Gage, F. H. (2008) · Cell · doi:10.1016/j.cell.2008.01.033 · Cited by 3,007
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Self-citation
Neurodegenerative Tauopathies
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480

Show all 175 references

Research works printed but not linked: 9

1998, Trends in cell biology, 8, 125
2004, 127, 601
1997, 19, 939
2003, 37, 925
2006, 52, 831
2007, 55, 697
Smith, 2001, Cell Growth & Differentiation, 12, 277
1997, 18, 29
2005, 48, 825

Sorted by citations

Items 701–774 of 774

Insular Korteks ve Epilepsi
Fahrioğlu, S. L., Yılmaz, İ., & İlgi, S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1675
İyonlaştırıcı Olmayan Radyasyonun Yaşamımızdaki Yeri
Yavaş, M. C. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1673
Amiloid Beta Peptidler: in-vitro Alzheimer Hastalığı Toksisite Modellerinde Kullanımları
Kurt, S., & Çam, F. S. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1678
Dalak Anatomisi ve Klinik Önemi
Erbek, E., & BOLATLI, G. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1674
Gebelikte Parasetamol (Asetaminofen) Kullanımı Güvenli mi?
Şen, F. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1676
T Lenfosit Gelişimi
Köse, H. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1670
Hücre Membranı Enzimolojisi
Coşar, A. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1672
Sağlık Bilimleri Araştırmaları: Temel Tıp- IV
Kaya, H., Ibrahim Halil GAZIANTEP UNIVERSITY KILIC, Akçılar, R., Köse, H., Özüpek, G., Altay, İ. S., Coşar, A., Yavaş, M. C., Erbek, E., BOLATLI, G., et al. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384
Yerel bir virüsten Yeni Bir Epidemiye mi? Maymun Çiçeği Virüsü (Monkeypox) Virüsü Yapısı
Bozlak, Ç. E. B. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1681
Salmonella spp. Enfeksiyonları
Gümüşburun, S. A., Demirdöğen, Y., Vural, U., Boyraz, E. F., & Eslami, M. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1679
Effects of Radiofrequency Radiations on the Male Reproductive System
Yavaş, M. C. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub384.c1680
Blood brain barrier and its significance in drug delivery to brain in Alzheimer disease
Rana, D., Salave, S., Khunt, D., & Benival, D. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00018-2 · Cited by 1
Sobrecarga de cobre y enfermedad de Alzheimer, búsqueda de posibles blancos terapéuticos
Zubillaga, M. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/165188
Chapter 43. Agents for Neurocognitive Disorders
Ayers, G. M., & Brown, F. W. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as43
Unveiling the complexity of Alzheimer's disease: Introduction and its pathophysiology
Shabir, S., & Singh, M. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15540-6.00012-4
Comment on “Relationships between muscle strength, lung function, and cognitive function in Chinese middle-aged and older adults: A study based on the China health and retirement longitudinal study (CHARLS)”
Wang, X. (2024) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2024.11.002
The effects of Saccharomyces boulardii on TLR4/NF-κB neuroinflammatory pathway in the hippocampus of LPS-induced rats
Akhbari, M., Babaei, F., Navidi-Moghaddam, A., Ghafghazi, S., Khodabandehloo, F., Sarookhani, M. R., Dargahi, L., Mohammadi, G., & Nassiri‐Asl, M. (2026) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2026.06.008
“Because neurodegeneration — marked by synaptic damage and neuronal loss — is a primary cause of cognitive impairment in AD (Crews and Masliah, 2010), we assessed neuronal changes in the hippocampus.”
Imaging Alzheimer’s Retinopathy
Gaire, B. P., Koronyo, Y., Shi, H., Rentsendorj, A., Dumitrascu, O. M., Vit, J., Doustar, J., Black, K. L., Fuchs, D.-T. S., & Koronyo‐Hamaoui, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-72156-4_6
Role of Hepatic Lipoprotein Receptor-related Protein 1 (LRP-1) on Amyloid Beta Pathology in a Mouse Model of Amyloidosis
Panchal, U. R. (2025) · Chapman University Digital Commons (Chapman University) · doi:10.36837/chapman.000657
Application of Biopharmaceuticals in the Treatment of Neurological Diseases
Wang, Z. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2025.au23567
Methylomic signatures of tau and amyloid-beta in transgenic mouse models of Alzheimer’s disease neuropathology
Leung, S. K., Walker, E., Policicchio, S. S. S., Dahir, A., Vellame, D. S., Smith, A. R., Swarbrick, R., Lunnon, K., Dempster, E. L., Ahmed, Z., et al. (2026) · npj Dementia · doi:10.1038/s44400-026-00074-y · Cited by 2
“A comprehensive characterization of epigenetic alterationsinAD-relevantmousemodelscouldprovidecriticalinsightsinto earlymechanisticchangesthatprecedeovertlatestagesofdiseaseandmay revealnoveltargetsfortherapeuticintervention.”
Coffee and Cognitive Function
Cicero, A. F. G., & Micoli, V. D. (2025) · Springer eBooks · doi:10.1007/978-3-031-93459-9_7
The Icelandic mutation APPA673T on amyloid-β plaque burden in the 5xFAD Alzheimer modelPreprint
Anschuetz, A., Listyono, R., Vorley, T., Platt, B., Harrington, C. R., Riedel, G., & Schwab, K. (2025) · bioRxiv · doi:10.1101/2025.11.05.686739
“Neuronal loss is a further key pathological feature of neurodegenerative disease such as AD (Crews and Masliah, 2010).”
Heavy metals, behavior, and neurodegeneration: using Caenorhabditis elegans to untangle a can of worms
Caito, S. W., & Aschner, M. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1001-0_15
Additional file 2 of Quantifying the proportion of different cell types in the human cortex using DNA methylation profiles
Hannon, E. J., Dempster, E. L., Davies, J. P., Chioza, B. A., Blake, G. E. T., Burrage, J., Policicchio, S. S. S., Franklin, A., Walker, E., Bamford, R. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26672745
Additional file 2 of Behavioral, neuromorphological, and neurobiochemical effects induced by omega-3 fatty acids following basal forebrain cholinergic depletion in aged mice
Cutuli, D., Landolfo, E., Nobili, A., Bartolo, P. D., Sacchetti, S., Chirico, D., Marini, F., Pieroni, L., Ronci, M., D’Amelio, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13245943
Additional file 4 of Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
Bathe, T., Hery, G. P., Villareal, J. A. B., Phillips, J. L., Cohen, E. M., Sharma, R. V., Tsering, W., & Prokop, S. (2024) · Figshare · doi:10.6084/m9.figshare.26702602
Additional file 2 of Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
Bathe, T., Hery, G. P., Villareal, J. A. B., Phillips, J. L., Cohen, E. M., Sharma, R. V., Tsering, W., & Prokop, S. (2024) · Figshare · doi:10.6084/m9.figshare.26702596
Additional file 1 of Impact of seed amplification assay and surface-enhanced Raman spectroscopy combined approach on the clinical diagnosis of Alzheimer’s disease
D’Andrea, C., Cazzaniga, F. A., Bistaffa, E., Barucci, A., de Angelis, M., Banchelli, M., Farnesi, E., Polykretis, P., Marzi, C., Indaco, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26603680
Additional file 4 of METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events
Zhao, F., Xu, Y., Gao, S., Qin, L., Austria, Q. M., Siedlak, S. L., Pajdzik, K., Dai, Q., He, C., Wang, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16713986
Additional file 5 of METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events
Zhao, F., Xu, Y., Gao, S., Qin, L., Austria, Q. M., Siedlak, S. L., Pajdzik, K., Dai, Q., He, C., Wang, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16713989
Additional file 3 of Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
Bathe, T., Hery, G. P., Villareal, J. A. B., Phillips, J. L., Cohen, E. M., Sharma, R. V., Tsering, W., & Prokop, S. (2024) · Figshare · doi:10.6084/m9.figshare.26702599
Additional file 3 of METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events
Zhao, F., Xu, Y., Gao, S., Qin, L., Austria, Q. M., Siedlak, S. L., Pajdzik, K., Dai, Q., He, C., Wang, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16713983
Additional file 1 of METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events
Zhao, F., Xu, Y., Gao, S., Qin, L., Austria, Q. M., Siedlak, S. L., Pajdzik, K., Dai, Q., He, C., Wang, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16713977
Additional file 2 of METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events
Zhao, F., Xu, Y., Gao, S., Qin, L., Austria, Q. M., Siedlak, S. L., Pajdzik, K., Dai, Q., He, C., Wang, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16713980
Additional file 6 of METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events
Zhao, F., Xu, Y., Gao, S., Qin, L., Austria, Q. M., Siedlak, S. L., Pajdzik, K., Dai, Q., He, C., Wang, W., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16713992
Additional file 1 of Behavioral, neuromorphological, and neurobiochemical effects induced by omega-3 fatty acids following basal forebrain cholinergic depletion in aged mice
Cutuli, D., Landolfo, E., Nobili, A., Bartolo, P. D., Sacchetti, S., Chirico, D., Marini, F., Pieroni, L., Ronci, M., D’Amelio, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13245940
Additional file 1 of Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
Bathe, T., Hery, G. P., Villareal, J. A. B., Phillips, J. L., Cohen, E. M., Sharma, R. V., Tsering, W., & Prokop, S. (2024) · Figshare · doi:10.6084/m9.figshare.26702593
Additional file 1 of Quantifying the proportion of different cell types in the human cortex using DNA methylation profiles
Hannon, E. J., Dempster, E. L., Davies, J. P., Chioza, B. A., Blake, G. E. T., Burrage, J., Policicchio, S. S. S., Franklin, A., Walker, E., Bamford, R. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26672742
Influence of Neurotransmitters Disruption on the Deterioration of Cognitive Function
Gupta, P., Yadav, P., Shrivastava, S., & Soni, R. K. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-4627-4.ch001
Tyrosine Kinase as the Therapeutic Target for Neurodegenerative Diseases
Mandal, N., Bej, A., Das, A., & Nandi, A. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-4627-4.ch010
VR‐based Gamma Sensory Stimulation: A feasibility study
Reis, C., Azizollahi, H., Headley, G., Navarro, S., Hanslmayr, S., Clouter, A., Zanto, T., & Certain, R. (2025) · Alzheimer s & Dementia · doi:10.1002/alz70859_106544
Comparative evaluation of large language models in retrieving known and predicting novel drug combinations
Wang, E. J., Oğuztüzün, Ç., Xu, R., & Gao, Z. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261415635 · Cited by 1
Recent Advances in Polyoxometalates Targeting Proteins Associated with Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Applications
Zhang, L., Lu, T., Hua, Z., Peng, S., Du, H., Zhai, X., Cai, Z., Hua, J., & Ma, X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031257 · Cited by 2
“Alzheimer’s disease (AD) is a neurodegenerative disorder of the central nervous system characterized by progressive cognitive decline, with complex and multifaceted pathogenic mechanisms [1].”
Hallucinogenic Therapy in Alzheimer’s Disease targeting Mitochondria-Associated Membranes
Minauro‐Sanmiguel, F., & Vargas-Pérez, H. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.02.028
Comparative Spectroscopic Investigation of Amyloid Beta Peptides Spin-Labeled with MTSL and PROF
Mause, J., Ebo, L., Hülsmann, M., Pierro, A., Godt, A., Drescher, M., & Azarkh, M. (2026) · Applied Magnetic Resonance · doi:10.1007/s00723-026-01829-9
Recent Alzheimer’s Research Targets Amyloid-β with Novel Phytochemicals and Pharmacological Strategies for Therapy
Sharma, S., Sharma, U., Sethiya, N. K., & Singh, L. (2026) · Current Aging Science · doi:10.2174/0118746098373086251201095903
Nanocarriers in Alzheimer’s Therapy: A Comprehensive Review on Nanoparticulate Drug Delivery Systems
Parashar, A. K., Saraogi, G. K., Sethi, V. A., & Yasin, H. K. A. (2026) · Current Neurovascular Research · doi:10.2174/0115672026435071260129105648
Validation préclinique de l'efficacité de l'ANAVEX2-73 dans des modèles transgénique et non transgénique de la maladie d'Alzheimer
Lahmy, V. (2014) · theses.fr (ABES) · doi:10.70675/23744d67zb26bz4a32zadbfz3931ecca70f5
Studies on the Role of Cellular Heparan Sulfate on Tau Pathology in Alzheimer's Disease and Related Tauopathies
Sepulveda-Diaz, J. E. (2013) · theses.fr (ABES) · doi:10.70675/56c42bcbz41dfz432bzbb78z77110b373285
Implication des métabolites de l'APP dans les troubles mnésiques précoces chez la souris TgCRND8, un modèle de la maladie d'Alzheimer
Hamm, V. (2016) · theses.fr (ABES) · doi:10.70675/39443da7z44bfz4b29zbbbezb2b0dfba178a
Measurement of morphological modifications of cell population using lensless imaging.
Kesavan, S. V. (2014) · doi:10.70675/d3b0535cz542cz4221za50azc5c8bcfcb0eb
AMPA receptor stabilization mediated by non-canonical Wnt signaling protects against Aβ42 oligomers synaptotoxicity
Montecinos-Oliva, C. (2018) · theses.fr (ABES) · doi:10.70675/1cb0a505zb904z4045z83b4z7ec8f3bc62b9
Nouvelles méthodologies en spectrométrie de masse native et mobilité ionique pour la caractérisation structurale de protéines d'intérêt thérapeutique et de complexes multiprotéiques
Botzanowski, T. (2019) · theses.fr (ABES) · doi:10.70675/52092372ze4efz4025za8a7zc54782872e52
Membranes biomimétiques pour la caractérisation de nouveaux agents thérapeutiques : application à la maladie d'Alzheimer
Smeralda, W. (2019) · theses.fr (ABES) · doi:10.70675/16bb8ffez6612z4ceeza7e1zccb78a0024e8
Characterizing the Cellular and Molecular Effects of Neural Androgen Receptor Invalidation in Male Mice
Karameh, N. (2018) · theses.fr (ABES) · doi:10.70675/b70b7c03z8de8z4ee0z9848z381e95568515
How exercise improves Alzheimer's disease
Niu, Y.-M. (2023) · Integrate Medicine · doi:10.61958/imkk9385
Pathological Remuneration of Oxidative Stress in Limiting Gut-Brain Axis
Kumar, R., Kashyap, A., & Naqvi, S. (2026) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-032-19837-2_5
Propranolol reinstates mitochondrial dynamics and synaptic memory pathways through CaMKII/CREB–BDNF/ PKMζ cascades in an AD-like rat model
Pinky, Neha, Kaushik, M., Tiwari, P., El‐Tanani, M., Rabbani, S. A., & Parvez, S. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1729046
“It is well recognized that CREB is essential to the basic processes of memory and learning as well as to additional complicated brain activities including addiction, anxiety, and depression (Crews and Masliah, 2010).”
Redirecting Alzheimer's disease therapeutics: Multitarget drugs and complementary non‐pharmacological strategies
Martínez-Orozco, H., Andrade-Guerrero, J., Pasten-Castrejón, N. J., Rodríguez‐Tanty, C., & Díaz-Cintra, S. Y. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71589
“14 However, AD etiology also involves A β -independent mechanisms.”
Neuroinflammation, Pericyte Dysfunction, and Alzheimer’s Disease-Associated Gene Expression and Pathway Activation in the Brain of SARS-CoV-2-Infected Mice
Lawal, A. O., Jacob, I. B., Karnik, V., Fan, H., Thangamani, S., Massa, P. T., & Wang, G. (2026) · Viruses · doi:10.3390/v18070783
“The positive lesions include amyloid plaques, tau-containing neurofibrillary tangles, and glial activation, while the negative lesions comprise synaptic damage, neuronal loss, and general brain atrophy [41–43].”
Regulation of different kinases for Alzheimer's disease therapy: progresses and perspectives
Han, M., Liao, Q., He, S., Guo, L., Lu, Z., Wang, X., Sun, W., Duan, Y. B., Lyu, W., & Li, Q. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110300
Gut Microbiome Changes in Preclinical Alzheimer’s Disease
Dissanayaka, S. U., Rainey‐Smith, S. R., Sohrabi, H. R., Jayasinghe, T. N., Ho, V., Jayasena, V., Taddei, K., Masters, C. L., Martins, R. N., & Fernando, W. M. A. D. B. (2026) · Nutrients · doi:10.3390/nu18152469 · Cited by 1
“The amyloid cascade hypothesis proposes that abnormal accumulation of A β characterises an early pathological event that initiates downstream processes, including tau pathology, neuroinflammation, synaptic dysfunction, and neurodegeneration [39,40].”
Demenz: Alzheimerkrankheit
O’Brien, K., & Blair, P. (2026) · Springer eBooks · doi:10.1007/978-3-032-14521-5_9
Glyco you should know
Mahajan, S. (2026) · Glycobiology · doi:10.1093/glycob/cwag063
Rethinking Senescence Hallmarks in the Brain: Lessons From Peripheral Tissues and Challenges in Defining Neuronal Senescence
Momand, M. U. D., Macová, K., & Fričová, D. (2026) · Aging Cell · doi:10.1111/acel.70719
Effects of long‐term daily supplementation with vitamin D3 and marine omega‐3 fatty acids on change in ADRD biomarkers: A secondary analysis of a randomized clinical trial
Vyas, C. M., Ostaszewski, B. L., Anderson, A. K., Cook, N. R., Kang, J. H., Mischoulon, D., Reynolds, C. F., Chang, G., Gatchel, J. R., Manson, J. E., et al. (2026) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70312
Histone modifications and chromatin landscapes in microglial function: Developmental imprinting and disease-associated reprogramming
Li, X., Rong-liang, G., Teng, Z., Liu, P.-P., & Liu, C. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103377
BindingDB Entry 50023403: Targeting JNK3 for Alzheimer's disease: Design and synthesis of novel inhibitors with aryl group diversity utilizing wide pocket.
BindingDB (2026) · UC San Diego · doi:10.7270/q2mw2p23
BindingDB Entry 50019215: Targeting Death-Associated Protein Kinases for Treatment of Human Diseases: Recent Advances and Future Directions.
BindingDB (2024) · UC San Diego · doi:10.7270/q21v5k9h
BindingDB Entry 50020721: Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease.
BindingDB (2024) · UC San Diego · doi:10.7270/q2bk1hvc
BindingDB Entry 50019685: Carbamate JNK3 Inhibitors Show Promise as Effective Treatments for Alzheimer's Disease: In Vivo Studies on Mouse Models.
BindingDB (2024) · UC San Diego · doi:10.7270/q2v98df9
AVALIAÇÃO DOS EFEITOS DE COMPOSTOS POLIFENÓLICOS EM PARÂMETROS BIOQUÍMICOS E NO TRATAMENTO DE DÉFICITS COGNITIVOS ASSOCIADOS À ADMINISTRAÇÃO DE ESCOPOLAMINA EM PEIXE ZEBRA ( Danio rerio )
Richetti, S. K. (2010) · Americanae (AECID Library)
Toll-Like Receptor 2 and Partner Receptors in Alzheimers Disease
Shirong, L. (2011) · Publications of the UdS (Saarland University) · doi:10.22028/d291-21508

Authors: Crews, L., & Masliah, E.
Affiliations: University of California San Diego (US)
Corresponding author: Masliah, E.
ORCID: Crews, L.
Masliah, E.
Venue: Human Molecular Genetics
Publisher: Oxford University Press (OUP)
Published: 2010-04-15
Volume: 19
Issue: R1
Pages: R12-R20
ISSN: 0964-6906 (ISSN-L)
1460-2083
DOI: 10.1093/hmg/ddq160
PMC: PMC2875049
OpenAlex: W2135957529
Cited by: 772
References: 175
Citations by year: 2026: 33 · 2025: 53 · 2024: 56 · 2023: 71 · 2022: 48 · 2021: 76 · 2020: 69 · 2019: 50 · 2018: 47 · 2017: 47 · 2016: 42 · 2015: 34 · 2014: 31 · 2013: 35 · 2012: 40
FWCI: 3.70
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Human Molecular Genetics (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (AG5131, NS4 4233, AG‐18440, AG10435, AG11385)
National Institute on Aging (P01AG010435, AG-11385, P50AG005131, AG-5131, AG 18440, AG10435)
National Institute of Neurological Disorders and Stroke (P01NS044233, NS-44233)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, neurodegeneration, amyloid-beta oligomers, amyloid plaques, tau hyperphosphorylation, neurofibrillary tangles, synaptic loss, adult hippocampal neurogenesis, glutamate receptors, excitotoxicity, mitochondrial dysfunction, lysosomal dysfunction, synaptic plasticity, Fyn, glycogen synthase kinase-3β, cyclin-dependent kinase 5, anti-aggregation therapy, amyloid-beta clearance
MeSH terms: Alzheimer Disease, Humans, Amyloid beta-Peptides, Neurogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mechanisms of neurodegeneration in Alzheimer's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks